Contact

All Stories

  1. Paper mills in evidence synthesis: reported involvement among retracted systematic reviews and meta-analyses

    Article • Journal of Clinical Epidemiology, October 2026, Elsevier

    Faruk Skenderi

  2. Response to the Letter regarding “The role of reviewers in the era of systematic reviews and meta-analysis: A practical guide for researchers”

    Article • Biomolecules and Biomedicine, April 2026, Association of Basic Medical Sciences of FBIH

    Faruk Skenderi

  3. <p>Who Corrupted the Evidence Pyramid? Retractions and Paper Mills in Systematic Reviews and Meta-Analyses</p>

    Article • January 2026, Elsevier

    Faruk Skenderi

  4. Glycogen-Rich Clear Cell Carcinoma of the Breast: Report of Two New Cases and an Updated Literature Review

    Article • Acta Medica Academica, December 2025, Academy of Sciences and Arts of Bosnia and Herzegovina

    Faruk Skenderi

  5. Acinic Cell Carcinoma of the Breast: A Population‐Based Clinicopathologic Study

    Article • Cancer Reports, October 2025, Wiley

    Faruk Skenderi

  6. The role of reviewers in the era of systematic reviews and meta-analysis: A practical guide for researchers

    Article • Biomolecules and Biomedicine, July 2025, Association of Basic Medical Sciences of FBIH

    Faruk Skenderi

  7. From BJBMS to Biomolecules and Biomedicine: A new chapter

    Article • Biomolecules and Biomedicine, June 2025, Association of Basic Medical Sciences of FBIH

    Faruk Skenderi

  8. Abstract P1-11-17: High Tumor-Infiltrating Lymphocyte Levels Correlate with High MammaPrint® Recurrence Risk in Early-Stage Breast Carcinomas

    Article • Clinical Cancer Research, June 2025, American Association for Cancer Research (AACR)

    Faruk Skenderi

  9. Acinic Cell Carcinoma of The Breast: A Population-Based Clinicopathologic Study

    Article • May 2024, Springer Science + Business Media

    Faruk Skenderi

  10. The assessment of tumor-infiltrating lymphocytes in invasive apocrine carcinoma of the breast in relation to the HER2 status

    Article • Biomolecules and Biomedicine, March 2024, Association of Basic Medical Sciences of FBIH

    Faruk Skenderi

  11. Bosnian Journal of Basic Medical Sciences becomes Biomolecules and Biomedicine

    Article • Biomolecules and Biomedicine, January 2023, Association of Basic Medical Sciences of FBIH

    Faruk Skenderi

  12. Comprehensive genomic profiling of a metastatic small cell lung carcinoma with a complete and long-term response to atezolizumab: A case report

    Article • Respiratory Medicine Case Reports, January 2023, Elsevier

    Faruk Skenderi

  13. A tribute to Prof. Ondrej Hes, MD, PhD (1968–2022)

    Article • Modern Pathology, December 2022, Elsevier

    Faruk Skenderi

  14. Acinic cell carcinoma of the breast: A comprehensive review

    Article • The Breast, December 2022, Elsevier

    Faruk Skenderi

  15. Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional study

    Article • Annals of Diagnostic Pathology, October 2022, Elsevier

    Faruk Skenderi

  16. HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome

    Article • Breast Cancer Research and Treatment, March 2022, Springer Science + Business Media

    Faruk Skenderi

  17. HER2-positive Apocrine Carcinoma of the Breast: A population-based Analysis of Treatment and Outcome

    Article • February 2022, Springer Science + Business Media

    Faruk Skenderi

  18. HER2-positive Apocrine Carcinoma of the Breast: A population-based Analysis of Treatment and Outcome

    Article • January 2022, Research Square

    Faruk Skenderi

  19. Correlation of Expression of TGF- β and MMP2 between Prostatic Adenocarcinoma and Adjacent Unaffected Parenchyma

    Article • Acta Clinica Croatica, January 2022, Sestre Milosrdnice University Hospital Center (KBC Sestre milosrdnice)

    Faruk Skenderi

  20. TERT Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors

    Article • Clinical Genitourinary Cancer, August 2021, Elsevier

    Faruk Skenderi

  21. Isolated deep orbital hemangioma treated successfully with oral propranolol in a 2-month-old infant: Case report with literature review

    Article • American Journal of Ophthalmology Case Reports, June 2021, Elsevier

    Faruk Skenderi

  22. A Giant, Complex Fibroepithelial Tumor of the Breast: Borderline Phyllodes Tumor Combined with Tubular Adenoma − a Rare Clinical Presentation of a Fibroepithelial Tumor of the Breast

    Article • Acta Medica Academica, May 2021, Academy of Sciences and Arts of Bosnia and Herzegovina

    Faruk Skenderi

  23. Unexpected adrenal pheochromocytoma associated with a generalized tonic-clonic seizure in a prepubertal boy

    Article • Medicine, January 2021, Wolters Kluwer Health

    Faruk Skenderi

  24. A Case of Extra-adrenal Retroperitoneal Ganglioneuroma in a 9-year-old Female: A New Case Report with a Comprehensive Literature Review

    Article • The Central European Journal of Paediatrics, November 2020, Acta Medica Saliniana

    Faruk Skenderi

  25. Co-Incidence of Human Papillomaviruses and Epstein–Barr Virus is Associated with Advanced Tumor Stage: A Tissue Microarray Study of Head and Neck Cancers

    Article • October 2020, Qatar University

    Faruk Skenderi

  26. KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas

    Article • BMC Medical Genetics, October 2020, Springer Science + Business Media

    Faruk Skenderi

  27. Co-presence of human papillomaviruses and Epstein–Barr virus is linked with advanced tumor stage: a tissue microarray study in head and neck cancer patients

    Article • Cancer Cell International, August 2020, Springer Science + Business Media

    Faruk Skenderi

  28. Giant Paratubal Serous Cystadenoma in an Adolescent Female: Case Report and Literature Review

    Article • Journal of Pediatric and Adolescent Gynecology, August 2020, Elsevier

    Faruk Skenderi

  29. Molecular Profiling of the Metaplastic Spindle Cell Carcinoma of the Breast Reveals Potentially Targetable Biomarkers

    Article • Clinical Breast Cancer, August 2020, Elsevier

    Faruk Skenderi

  30. High-Risk Human Papillomaviruses and Epstein–Barr Virus in Colorectal Cancer and Their Association with Clinicopathological Status

    Article • Pathogens, June 2020, MDPI AG

    Faruk Skenderi

  31. 2020 consensus guideline for optimal approach to the diagnosis and treatment of HER2-positive breast cancer in Bosnia and Herzegovina

    Article • Bosnian Journal of Basic Medical Sciences, May 2020, Association of Basic Medical Sciences of FBIH

    Faruk Skenderi

  32. Novel targetable biomarkers in clear cell carcinoma of the breast uncovered by molecular profiling: A study of nine cases

    Article • The Breast Journal, April 2020, Wiley

    Faruk Skenderi

  33. Typical and atypical carcinoid tumors of the lung: a clinicopathological correlation of 783 cases with emphasis on histological features

    Article • Human Pathology, April 2020, Elsevier

    Faruk Skenderi

  34. Glycogen-rich Clear Cell Carcinoma of the Breast: A Comprehensive Review

    Article • Applied Immunohistochemistry & Molecular Morphology, March 2020, Wolters Kluwer Health

    Faruk Skenderi

  35. A Free Terminal Ileal Perforation as the Presenting Sign of Crohn’s Disease in an Adolescent Female

    Article • The Central European Journal of Paediatrics, March 2020, Acta Medica Saliniana

    Faruk Skenderi

  36. Dishevelled family proteins in serous ovarian carcinomas: a clinicopathologic and molecular study

    Article • Apmis, January 2020, Wiley

    Faruk Skenderi

  37. A Successful Treatment of Encapsulating Peritoneal Sclerosis in an Adolescent Boy on Long-term Peritoneal Dialysis: A Case Report

    Article • Prague Medical Report, January 2020, Charles University in Prague, Karolinum Press

    Faruk Skenderi

  38. Critical appraisal of predatory journals in pathology

    Article • Journal of Clinical Pathology, November 2019, BMJ

    Semir Vranic, Faruk Skenderi

  39. 200PEffects of delayed initiation of adjuvant trastuzumab for non-metastatic, HER2 positive breast cancer in a limited resources setting: ML25232 study final results

    Article • Annals of Oncology, October 2019, Oxford University Press (OUP)

    Faruk Skenderi

  40. 58PSpindle cell carcinoma of the breast: Rare cancer with potentially targetable biomarkers

    Article • Annals of Oncology, May 2019, Oxford University Press (OUP)

    Faruk Skenderi

  41. Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma

    Article • PLOS One, April 2019, PLOS

    Faruk Skenderi

  42. Letter to the Editor/Response

    Article • The Breast Journal, April 2019, Wiley

    Faruk Skenderi

  43. Papillary pattern in clear cell renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 23 cases

    Article • Annals of Diagnostic Pathology, February 2019, Elsevier

    Faruk Skenderi

  44. Somatostatin receptor SSTR2A and SSTR5 expression in neuroendocrine breast cancer

    Article • Annals of Diagnostic Pathology, February 2019, Elsevier

    Faruk Skenderi

  45. A Critical Appraisal of Predatory Journals in Pathology

    Article • December 2018, Cold Spring Harbor Laboratory Press

    Faruk Skenderi

  46. A clinicopathologic study of invasive apocrine carcinoma of the breast: A single-center experience

    Article • The Breast Journal, September 2018, Wiley

    Faruk Skenderi

  47. 23. Prevalence of KANK1-NTRK3 fusion in renal metanephric adenomas that lack BRAF mutations

    Article • Cancer Genetics, August 2018, Elsevier

    Faruk Skenderi

  48. Neoadjuvant trastuzumab + pertuzumab in HER2 positive breast cancer in a country with limited resources: Evaluation of complete pathological response in a real world practice.

    Article • Journal of Clinical Oncology, May 2018, American Society of Clinical Oncology (ASCO)

    Faruk Skenderi

  49. Clinicopathologic characteristics of invasive apocrine carcinoma of the breast: A single center experience from a country with limited resources

    Article • European Journal of Cancer, April 2018, Elsevier

    Faruk Skenderi

  50. 67PDNA promoter methylation status and protein expression of SHh and IHh in serous ovarian carcinomas

    Article • Annals of Oncology, March 2018, Oxford University Press (OUP)

    Faruk Skenderi

  51. Review of Gynecologic and Breast Pathology

    Article • January 2018, Jaypee Brothers Medical Publishing

    Faruk Skenderi

  52. Methylation-associated silencing of SFRP1 gene in high-grade serous ovarian carcinomas

    Article • Annals of Diagnostic Pathology, December 2017, Elsevier

    Faruk Skenderi

  53. Renal Cell Carcinoma With Leiomyomatous Stroma

    Article • Applied Immunohistochemistry & Molecular Morphology, October 2017, Wolters Kluwer Health

    Faruk Skenderi

  54. Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases

    Article • Annals of Diagnostic Pathology, April 2017, Elsevier

    Faruk Skenderi

  55. Whorling cellular perineurioma: A previously undescribed variant closely mimicking monophasic fibrous synovial sarcoma

    Article • Annals of Diagnostic Pathology, April 2017, Elsevier

    Faruk Skenderi

  56. Cystic and necrotic papillary renal cell carcinoma: prognosis, morphology, immunohistochemical, and molecular-genetic profile of 10 cases

    Article • Annals of Diagnostic Pathology, February 2017, Elsevier

    Faruk Skenderi

  57. Skeletal Muscle Metastases from Squamous Cell Carcinoma of the Cervix

    Article • International Journal of Gynecological Pathology, January 2017, Wolters Kluwer Health

    Faruk Skenderi

  58. Breast cancer incidence, demographic, and pathological characteristics in Bosnia and Herzegovina

    Article • September 2016, Morressier

    Faruk Skenderi

  59. The members of Wnt pathway SFRP1, SFRP3, and DVL1 are downregulated in testicular germ cell tumours

    Article • September 2016, Morressier

    Faruk Skenderi

  60. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant

    Article • Virchows Archiv, September 2016, Springer Science + Business Media

    Faruk Skenderi

  61. The expression of SFRP1, SFRP3, DVL1, and DVL2 proteins in testicular germ cell tumors

    Article • Apmis, September 2016, Wiley

    Faruk Skenderi

  62. Solid papillary renal cell carcinoma: clinicopathologic, morphologic, and immunohistochemical analysis of 10 cases and review of the literature

    Article • Annals of Diagnostic Pathology, August 2016, Elsevier

    Faruk Skenderi

  63. Molecular Genetic Alterations in Renal Cell Carcinomas With Tubulocystic Pattern

    Article • Applied Immunohistochemistry & Molecular Morphology, August 2016, Wolters Kluwer Health

    Faruk Skenderi

  64. Mammary Analogue Secretory Carcinoma (MASC) of the salivary gland: A new tumor entity

    Article • Bosnian Journal of Basic Medical Sciences, April 2016, Association of Basic Medical Sciences of FBIH

    Faruk Skenderi

  65. “Mucin”-secreting papillary renal cell carcinoma: clinicopathological, immunohistochemical, and molecular genetic analysis of seven cases

    Article • Virchows Archiv, April 2016, Springer Science + Business Media

    Faruk Skenderi

  66. Low-grade malignant peripheral nerve sheath tumor: a report of the first case in the breast and literature review

    Article • Apmis, February 2016, Wiley

    Faruk Skenderi

  67. Cystic Renal Oncocytoma and Tubulocystic Renal Cell Carcinoma

    Article • Applied Immunohistochemistry & Molecular Morphology, February 2016, Wolters Kluwer Health

    Faruk Skenderi

  68. Does everything a surgeon takes out have to be seen by a pathologist? A review of the current pathology practice

    Article • Virchows Archiv, July 2015, Springer Science + Business Media

    Faruk Skenderi

  69. Regulated cell death in diagnostic histopathology

    Article • The International Journal of Developmental Biology, January 2015, UBC Press

    Faruk Skenderi

  70. Cystic renal oncocytoma and tubulocystic renal cell carcinoma: morphologic and immunohistochemical comparative study

    Article • Pathology, January 2014, Elsevier

    Faruk Skenderi

  71. Uterine cervix squamous cell carcinoma metastatic to the Ampulla of Vater: a case report with review of the literature

    Article • Journal of Health Sciences, September 2013, University of Sarajevo Faculty of Health Sciences

    Faruk Skenderi

  72. Infarcted fibroadenoma of the breast: report of two new cases with review of the literature

    Article • Diagnostic Pathology, February 2013, Springer Science + Business Media

    Faruk Skenderi

  73. First decade of publishing Bosnian Journal of Basic Medical Sciences

    Article • Bosnian Journal of Basic Medical Sciences, November 2011, Association of Basic Medical Sciences of FBIH

    Faruk Skenderi

  74. Polymorphism in Methylentetrahydrofolate Reductase Gene: Important Role in Diseases

    Article • Bosnian Journal of Basic Medical Sciences, May 2008, Association of Basic Medical Sciences of FBIH

    Faruk Skenderi